Mesoblast, recently dual listed on NASDAQ, concurred by many, to have been unfairly sold down by the Yanks, MASSIVE reversal due to occur/ occuring. CYP is similarly in Stem Cells research.
MSB sold down from 3.50 to 1.50. Currently 15% up close on Fri and over 22% up at the NASDAQ Fri close- anticipate at least a bounce back to 2.50 in the short term.
CYP has fallen from $1 to 31c last fri. Could the MSB market action and reversal possible to SPILL OVER into the CYP space??
The OCT presentation is impressive and informative for prospective investors. CYP market cap at 26Mill could be argued as being much too cheap as a peer comparision. When it moves, we may be talking about double digits%, not just pips.... question is when? Similar reversal by CYP to MSB could see in the 55-60c mark.
Good luck investors and potential investors! I thought the MSB action is relevant for a heads up!!
